U.S. court overturns bid by India's Ranbaxy to block launch of rival generic drugs
November 20, 2014 at 00:10 AM EST
Nov 20 (Reuters) - A U.S. court has denied a request by Indian drugmaker Ranbaxy Laboratories Ltd to stop competitors from launching copies of AstraZeneca Plc's heartburn pill Nexium and Roche's antiviral Valcyte, a court filing showed.